ArticleBMC neurology2026
Subclinical peripheral nerve demyelination without overt symptoms in a family with neuronal intranuclear inclusion disease harboring biallelic repeat expansions.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Neuronal intranuclear inclusion disease (NIID) is a rare, progressive neurodegenerative disorder caused by abnormal GGC repeat expansions in the NOTCH2NLC gene, leading to multisystem involvement. Electrophysiological abnormalities in NIID have gained increasing attention in recent years. However, subclinical peripheral neuropathy preceding the onset of typical NIID manifestations has not been reported. In this study, we systematically evaluated the clinical characteristics of a family carrying pathogenic NOTCH2NLC expansions. Electrophysiological assessments revealed demyelinating changes in some family members, with or without the classic clinical features of NIID. Notably, one individual with biallelic NOTCH2NLC GGC repeat expansions exhibited subclinical peripheral neuropathy in the absence of overt NIID symptoms. As NIID is typically inherited in an autosomal dominant manner, cases with biallelic GGC repeat expansions are exceedingly rare. To explore the genotype–phenotype relationship, we employed long-read whole-genome sequencing using Oxford Nanopore and Pacific Biosciences (PacBio) technologies. Our results suggest that biallelic repeat expansions do not necessarily exacerbate the severity or progression of NIID. Although larger studies are warranted to confirm these findings, this investigation broadens the clinical and genetic spectrum of NIID and provides new insights into its underlying pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.